Former Turing Pharmaceutical Chief Executive Martin Shkreli has invoked the Fifth Amendment by refusing to produce documents subpoenaed by a Senate committee investigating on prescription drug price ...

Martin Shkreli, the drug entrepreneur who defended his decision to raise the price of a life-saving AIDS drug from $13.50 to $750, went quiet Thursday at a Congressional committee, grinning instead of ...

Today, Martin Shkreli appeared before the House Oversight Committee to respond to some questions on drug pricing. The 32-year-old former head of Turin Pharmaceuticals has been soundly critiqued for ...

Benjamin Brafman writes: I accompanied Martin Shkreli to a congressional hearing on pharmaceutical pricing that he was compelled to attend, despite advance knowledge that he would invoke his Fifth ...